Insights

Cardiome Pharma Corp. today announced that it will report financial results for the second quarter ended June 30, 2014 on...

Total Revenue of $68.2 million, including Contract Revenue of $61.5 Million, up 15%   Adjusted Diluted EPS of $0.22, up...

Strong second quarter and first half results reported -- Full year 2014 sales and profit guidance increased -- Conference call...

McKesson Corporation (NYSE:MCK) today announced a three-year extension of its existing distribution agreement with CVS Caremark through June, 2019. “We...

Unique Pizza and Subs Corporation ("Unique," OTC Markets Groups Inc.: OTC Pink: UPZS), a Delaware Corporation, is pleased to announce...

Medical revenues in China- your guide to trends, companies and potentialsWhat's the outlook for the Chinese pharma market? Can it sustain high...

Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights   India Business grew by 20.87% to Rs....

SVP IX fund to invest primarily in late-stage biopharmaceutical companies. Sofinnova Ventures, a Menlo Park based investment firm, today announced...

- Investment to Foster Early Biotech Start-ups - Taiho Pharmaceutical Co., Ltd. (hereinafter "Taiho"), a fully-fledged oncology pharmaceutical company, announced...